Why the study?
Asian countries face an increasing prevalence of metabolic syndrome, which may aggravate cardiovascular disease burden and is closely associated with ambulatory blood pressure.
Metabolic syndrome is closely associated with masked hypertension and non-dipping blood pressure patterns, highlighting the clinical importance of 24-hour ambulatory blood pressure monitoring and long-acting antihypertensive therapy.
Answers are grounded in this paper and cite their sources.
Supports ABPM screening in metabolic syndrome; confirms observational links to masked hypertension and non-dipping.
Asian countries are facing an increasing prevalence of metabolic syndrome (MetS), which may aggravate the burden of cardiovascular diseases in this region. MetS is closely associated with ambulatory blood pressure (BP). Patients with MetS, compared to those without, had a twofold higher risk of new-onset office, home, or ambulatory hypertension. Furthermore, the risk of new-onset MetS in patients with white-coat, masked and sustained hypertension was also doubled compared to normotensives. High-risk masked hypertension and blunted nighttime BP dipping are common in patients with MetS, suggesting perfect 24-hour BP control with long-acting antihypertensive drugs and early initiation of combination therapy might be especially important for patients with MetS.
No takes yet. Share an insight, caveat, or question.
Huang et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: